Bioactiva Diagnostica Group, listed in Germany as an EN ISO 13485:2012 certified and registered manufacturer and supplier of in vitro diagnostic products, started in 2014 to offer a broad range of highest quality real-time PCR / RT-PCR, end-point fluorescence, and PCR reverse strip hybridization based tests for in-vitro nucleic acids detection. These tests comprise more than 500 different targets for the molecular analysis of various

  • Single human pathogens and pathogen panels,
  • Single cancer markers and cancer panels,
  • Human genetic diseases and genetic predispositions,
  • Somatic mutations with therapeutic implications in various cancers,
  • HLA and blood group typing,
  • Food pathogens, identification of meat species, allergens & genetically modified organisms (GMO),
  • Animal related diseases and zoonoses

Thus, Bioactiva`s molecular product portfolio is one of the most comprehensive in the world. The products satisfy highest quality standards and are compatible with most analytical platforms in the market. The vast majority of products are CE marked in vitro diagnostic products for human diagnostic application. Highlights are the fully CE/IvD marked hepatitis kit family (HAV, HBV, HCV, HDVnew, HEVnew), the Multiplex real time PCR tests to detect up to 30 different translocations in leukemia in one, the ALPHA and BETA Globin Testsnew, and the ZIKA Virus detection kitsnew.

To complete the product range basic PCR reagents such as enzymes, oligonucleotides, plastics, consumables and laboratory equipment e.g. real time PCR instruments required to operate a diagnostic PCR lab are available too. Products which are not under own manufacture are purchased from high innovative, well-respected international suppliers mainly located in Germany, Italy, France, Spain, UK, United States, and P.R. China.
Not to mention that the team offers professional support for the customers based on exceptional experience and practical know how around the clock.